• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS SANTA CLARA MYNXGRIP VASCULAR CLOSURE DEVICE 6F-7F; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS SANTA CLARA MYNXGRIP VASCULAR CLOSURE DEVICE 6F-7F; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number MX6721
Device Problem Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/07/2017
Event Type  malfunction  
Manufacturer Narrative
During integration of accessclosure, inc.Into the cordis business model, the determination was made that reportability for product failure modes would be aligned with current reportability for cordis products.This decision to align reportability was made, as the said failure modes, would not result in patient injury.As a result, this event is being filed beyond the 30-day fda requirement.(b)(6).(b)(4).Complaint conclusion: it was reported that a 6/f mynxgrip vascular closure device (vcd) could not cross through because of the tortuous vessel.There was no reported patient injury.The product is available for return.There were no damages or anomalies noted when removed from the package.The device prepped normally (i.E.Maintain negative pressure).The access site was located in the common femoral.The deployer was certified on mynx devices.The mynx (vcd) was prepped according to the instructions for use (ifu).The device was purged of air during the prep.There was no scar tissue present in the vicinity of the puncture site.A non-sterile mynxgrip vascular closure device 6f/7ff involved in the reported complaint was returned for investigation.Visual inspection of the returned device showed that the shuttle cartridge was disengaged from the handle.A 5f procedural sheath (off label use) was located on the polyimide shaft approximately 32 mm from the balloon proximal bond.The device¿s distal shaft was inspected for anomalies (i.E.Kinks, deformity that may have obstruct the device path during insertion).No anomalies were observed.A review of the manufacturing documentation associated with lot f1701302 presented no issues during the manufacturing process that can be related to the reported event.The failure reported as ¿could not cross through because of tortuous vessel¿ could not be confirmed due to the condition in which the unit was received for analysis.The tortuous vessel may have caused difficulty for the catheter tip to make the "turn" into the vessel.It was observed that the returned 6f/7f device was used with a 5f procedural sheath (off label use) during the procedure.The instructions for use (ifu) specifies that 5f or smaller sheaths must be exchanged to a 6f or 7f before inserting the mynx.Failure to follow the ifu by using a smaller than specified sheath size with a device may result in resistance during shuttling or a device jam.Neither the dhr review nor the product analysis suggests that the failure experienced by the customer is related to the mynx manufacturing process.Procedural factors and handling process may have contributed to the failure reported.No corrective or preventive actions will be taken at this time.Should additional relevant information become available, a supplemental mdr will be filed.
 
Event Description
It was reported that a 6/f mynxgrip vascular closure device (vcd) could not cross through because of tortuous vessel.There was no reported patient injury.The product is available for return.There were no damages or anomalies noted when removed from the package.The device prepped normally (i.E.Maintain negative pressure).The access site was located in the common femoral.The deployer was certified on mynx devices.The mynx (vcd) was prepped according to the instructions for use (ifu).  the device was purged of air during the prep.There was no scar tissue present in the vicinity of the puncture site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNXGRIP VASCULAR CLOSURE DEVICE 6F-7F
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer (Section G)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer Contact
librada contreras
5452 betsy ross drive
santa clara, CA 95054
MDR Report Key6906617
MDR Text Key89514693
Report Number3004939290-2017-00369
Device Sequence Number1
Product Code MGB
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 09/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/30/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2019
Device Model NumberMX6721
Device Catalogue NumberMX6721
Device Lot NumberF1700402
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/21/2017
Distributor Facility Aware Date06/08/2017
Date Manufacturer Received06/08/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/05/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-